PFIZER INC — Regulatory Filings 2007

Nov 15, 2007

8-K 1 k8pfe20070930.htm XBRL PFIZER 8-K XBRL SEC Pilot Pfizer Inc.

| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON,
D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of
1934 Date of Report (Date of earliest event reported): November 15, 2007 | | |
| --- | --- | --- |
| PFIZER INC. (Exact
name of registrant as specified in its charter) | | |
| DELAWARE (State or other jurisdiction of
incorporation) | 1-3619 (Commission File Number) | 13-5315170 (I.R.S. Employer Identification
No.) |
| 235 East 42nd Street, New York, New
York 10017 (Address of
principal executive offices) (zip code) (212) 573-2323 (Registrant's telephone
number) | | |

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions:

[ ] Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01. Other Events

Exhibit 100 to this Current Report on Form 8-K contains documents formatted in XBRL (eXtensible Business Reporting Language) with information from Pfizer Inc.'s Quarterly Report on Form 10-Q for the quarter ended September 30, 2007, filed with the Securities and Exchange Commission (SEC) on November 5, 2007. The information formatted in XBRL includes the (i) Condensed Consolidated Statements of Income for the three months and nine months ended September 30, 2007, and October 1, 2006, (ii) Condensed Consolidated Balance Sheets as of September 30, 2007, and at December 31, 2006, and (iii) Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2007 and October 1, 2006.

Users of this data are advised pursuant to Rule 401 of Regulation S-T that the financial information contained in the XBRL-Related Documents is unaudited and these are not the official financial statements of Pfizer Inc. as filed with the SEC. The purpose of furnishing these XBRL formatted documents is solely for the purpose of participation in the SEC's voluntary XBRL pilot program to test the related format and technology and, as a result, investors should continue to rely on the official filed version of the furnished documents and not rely on the information in this Current Report on Form 8-K, including Exhibit 100, in making investment decisions.

In accordance with Rule 402 of Regulation S-T, the information in this Current Report on Form 8-K, including Exhibit 100, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.

(d)
The following exhibits are furnished
herewith:
Exhibit
Number	Exhibit
Description
100	The following financial statements from
Pfizer Inc.'s Quarterly Report on Form 10-Q for the quarter ended September
30, 2007, filed on November 5, 2007, formatted in XBRL (extensible Business
Reporting Language): (i) the Condensed Consolidated Statements of Income
for the three months and nine ended September 30, 2007, and October 1,
2006, (ii) the Condensed Consolidated Balance Sheets as of September 30,
2007, and December 31, 2006, and (iii) the Condensed Consolidated Statements
of Cash Flows for the nine months ended September 30, 2007 and October
1, 2006.

SIGNATURE
Under the requirements of the Securities
Exchange Act of 1934, the registrant has caused this report to be signed
on its behalf by the authorized undersigned.
	PFIZER INC.
	By: /s/ Margaret M.
Foran
	Margaret M. Foran
Dated: November 15, 2007	Title: Senior Vice
President-Corporate Governance
	Associate General Counsel and Corporate
Secretary

EXHIBIT INDEX
Exhibit No.	Description
EX-100.INS	XBRL Instance Document
EX-100.SCH	XBRL Taxonomy Extension Schema
Document
EX-100.SCH.1	XBRL Schema Supplement Document
EX-100.CAL	XBRL Taxonomy Extension Calculation
Linkbase Document
EX-100.LAB	XBRL Taxonomy Extension Label Linkbase
Document
EX-100.PRE	XBRL Taxonomy Extension Presentation
Linkbase Document